Initial Case Series With Exalt Single-Use Duodenoscope
NCT03701958 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2022-02-08
Summary
To confirm procedural performance of the Exalt single-use duodenoscope in Endoscopic Retrograde Cholangio-Pancreatography (ERCP) procedures.
Conditions
- Endoscopic Retrograde Cholangiopancreatography
Interventions
- DEVICE
-
Exalt Model D Single-Use Duodenoscope
Subjects will have a clinically indicated per standard of care ERCP procedure performed with the Exalt single use duodenoscope study device.
Sponsors & Collaborators
-
Boston Scientific Corporation
lead INDUSTRY
Principal Investigators
-
V. Raman Muthusamy, MD · University of California, Los Angeles
-
Andrew Ross, MD · Virginia Mason Medical Center
Study Design
- Allocation
- NA
- Purpose
- DEVICE_FEASIBILITY
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-15
- Primary Completion
- 2019-05-06
- Completion
- 2019-06-07
Countries
- United States
Study Locations
More Related Trials
-
Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites
NCT01349335 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Losartan in Prevention of Post-ERCP Paancreatitis
NCT04049734 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH
NCT04378010 ·Status: TERMINATED ·Phase: PHASE2
-
Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)
NCT07216859 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Everolimus and LongActing Octreotide Trial in Polycystic Livers
NCT01157858 ·Status: COMPLETED ·Phase: PHASE2
-
Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)
NCT05516498 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study
NCT06078722 ·Status: UNKNOWN
-
A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers
NCT03207425 ·Status: COMPLETED ·Phase: PHASE1
-
FTIH of ECC4703 in Healthy Volunteers
NCT05552274 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis
NCT01766713 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3502970 in Participants With Impaired and Normal Liver Function
NCT05882032 ·Status: COMPLETED ·Phase: PHASE1
-
Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D
NCT07309380 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis
NCT03394924 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients
NCT02802228 ·Status: COMPLETED ·Phase: PHASE2
-
Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects
NCT06037577 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis
NCT03193502 ·Status: UNKNOWN ·Phase: PHASE3
-
The Use of Fibroscan to Assess Liver Fibrosis in Patients With Cardiac Pacemakers
NCT02415348 ·Status: UNKNOWN ·Phase: NA
-
Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects
NCT03748628 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
NCT03421431 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites
NCT01349348 ·Status: COMPLETED ·Phase: PHASE3
-
DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis
NCT07322237 ·Status: RECRUITING ·Phase: PHASE4
-
A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients
NCT02516605 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD
NCT05281328 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis
NCT03395704 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis
NCT00470171 ·Status: COMPLETED ·Phase: PHASE2